Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for CMV Prophylaxis in Stem Cell Transplant Recipients
NCT00045292Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Apr 2002
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of valaciclovir in cytomegalovirus infection (CMV), sponsored by Fred Hutchinson Cancer Center. Started Apr 2002; status: completed.
02
Drugs
valaciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00045292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045292.